Fig. 3From: Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancerIn vitro cellular uptake. (A) Fluorescence images of MOLM-13 cells incubated with different nanoparticles for 0.5 h; green represents C6 and blue represents nucleus. (B) Fluorescence images of HCT116 cells incubated with different nanoparticles for 0.5 h; green represents C6 and blue represents nucleus. (C) Flow cytometric analyses of MOLM-13 cells incubated with nanoparticles (n = 3). (D) Flow cytometric analyses of HCT116 cells incubated with nanoparticles (n = 3). ***p < 0.001Back to article page